Today: 26 June 2026
Apple stock price: AAPL heads into Monday after record quarter, but memory-chip costs loom
1 February 2026
1 min read

Apple stock price: AAPL heads into Monday after record quarter, but memory-chip costs loom

New York, Feb 1, 2026, 06:00 EST — Market closed.

Apple Inc shares closed Friday 0.46% higher at $259.48, after moving between $252.18 and $261.90 during the session. Volume hit roughly 92.4 million shares before U.S. markets shut down for the weekend.

The modest uptick arrived amid a Wall Street slump on Friday, as investors digested Donald Trump’s choice of Kevin Warsh to head the Federal Reserve alongside a stubbornly high inflation report. All eyes now shift to Apple’s next move, given its role as a key barometer for mega-cap tech sentiment.

Apple disclosed in an SEC filing that its quarterly revenue hit $143.8 billion, with diluted earnings per share at $2.84. iPhone sales reached $85.27 billion, while Services brought in $30.01 billion. Sales in Greater China climbed to $25.53 billion. CEO Tim Cook described the period as a “record-breaking quarter.” Meanwhile, CFO Kevan Parekh noted Apple generated nearly $54 billion in operating cash flow and returned close to $32 billion to shareholders, including $24.7 billion in share buybacks. SEC

Traders will zero in on Apple’s outlook and cost pressures next week. The company projects fiscal Q2 revenue growth between 13% and 16%, with gross margins expected in the 48% to 49% range. CEO Tim Cook warned that a tightening DRAM memory market could hit margins harder; Samsung Electronics and SK Hynix have both reported worsening shortages. eMarketer analyst Jacob Bourne noted this memory crunch might squeeze hardware profits. On top of that, Apple highlighted an AI partnership with Alphabet’s Google and a $1.6 billion acquisition of startup Q.ai.

Nikkei Asia reported that Apple intends to focus on three premium iPhone models in 2026, including a foldable version, pushing the standard iPhone 18 launch to the first half of 2027. Reuters, unable to independently confirm the report, noted Apple did not respond outside regular business hours.

Monday’s key question: can Apple maintain Friday’s close when trading restarts, or will it surrender gains as investors reassess the margin outlook? The memory cost trajectory is a crucial factor here.

Investors are bracing for a slew of analyst model revisions following the earnings release, focusing on Services growth and Apple’s pricing power amid ongoing component supply constraints.

The setup works both ways. Should iPhone demand slip after the holiday quarter or supply chain issues persist, Apple could struggle to offset rising memory costs without denting its profits.

Apple’s next fixed date to watch is the dividend. The company announced a regular cash payout of $0.26 per share, setting the record date for Feb. 9 and the payment date for Feb. 12.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Ascendis Pharma Shares Rally 9.9% on Strong Earnings Outlook
    June 26, 2026, 12:33 PM EDT. Ascendis Pharma (ASND) shares surged 9.9% to $261.58 on strong volume, driven by optimism over its marketed drugs Skytrofa and Yorvipath for growth hormone deficiency and hypoparathyroidism. The company is expected to report quarterly earnings of $1.29 per share, up 238.7% year-over-year, with revenue forecasts nearly doubling to $355.73 million. Despite this, consensus earnings estimates have slightly declined over the last month, a trend that historically does not support sustained price gains. ASND holds a Zacks Rank #3 (Hold). The related biomedical sector company Gilead Sciences (GILD) saw a 1.1% drop amid sharply lowered earnings forecasts. Investors should monitor Ascendis Pharma closely for signs of continued strength amid mixed earnings revision trends.

Latest News

Netflix (NASDAQ:NFLX) rebound leaves $175 billion Wall Street divide

Netflix (NASDAQ:NFLX) rebound leaves $175 billion Wall Street divide

26 June 2026
Netflix (NASDAQ:NFLX) jumped 5.9% to $75.10 after hitting a 20-month low, but the stock still trades far below the $115.82 average analyst target, leaving a $175 billion equity value gap; with 2027 EPS estimates steady and Q2 results due July 16, investors are watching whether ads and earnings can close the gap.
Ondas (NASDAQ:ONDS) shares up as Russell inclusion coincides with resale filing

Ondas (NASDAQ:ONDS) shares up as Russell inclusion coincides with resale filing

26 June 2026
Ondas shares jumped to $7.89 as the company joined the Russell 3000 index and filed to register 3.38 million acquisition-linked shares for resale, a move that adds saleable stock to the market but is limited by daily volume caps; the stock is up 21.5 cents on heavy volume, with index reconstitution and share flow in focus.
Bradesco sees surge in trading as dividend hunt runs into credit worries

Bradesco sees surge in trading as dividend hunt runs into credit worries

26 June 2026
Banco Bradesco S.A. (BVMF:BBDC4) surged 2.44% to R$18.05 on Friday with trading volume 25% above average, as investors chased a June interim interest on equity payout worth about 1.9% of the share price—18 times the regular monthly payout—while the stock remains 17% below its 52-week high.
Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday
Previous Story

Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next
Next Story

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next

Go toTop